Research use only Batch-level traceability HPLC / COA documentation workflow Peptides, blends and lab solutions
Metabolic & Incretin

HGH 176-191

HGH C-Terminal Fragment Research Peptide for hGH fragment 176-191 pathway research research models, supplied as lyophilized powder for qualified laboratory review.

+99% Purity Third-Party Tested COA Available
Available Presentations

Selected: 5 mg. Mention the exact presentation when requesting documentation.

Purity>99%
BatchFR010-310526
FormLyophilized Powder
Pack10 Vials

Technical Specifications

Primary analytical and handling data aligned to the current product record.

Molecular Formula C78H123N23O23S2
Molecular Weight 1815.1 g/mol
Sequence

Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe

Product FormLyophilized Powder
Presentation5 mg / 10 Vials
Batch NumberFR010-310526
TestingHPLC purity verification; third-party COA recommended for final release
AppearanceWhite to off-white lyophilized powder
StorageStore according to batch COA and internal laboratory SOP. Protect from light and avoid repeated freeze-thaw cycles where applicable.
Research UseResearch Use Only (RUO)

Research FAQ — HGH 176-191

Frequently asked questions about this compound for laboratory researchers.

What is HGH 176-191?

This page lists the research-use profile, presentation range, technical specifications, and batch-aligned documentation path for this compound.

How should documentation be requested?

Use the exact compound name, presentation, and batch number when requesting a certificate or availability confirmation.

Which presentation should I reference?

Always reference the specific amount shown in the presentation selector and match it to the corresponding batch record.

How should HGH 176-191 be stored?

Follow the storage conditions listed in the Technical Specifications section and batch documentation.